WST · 8-K · 20261029PR000118

Share Repurchase Program

WEST PHARMACEUTICAL SERVICES INC · 2026-10-29 · Importance 69 · Surprise 64 · In source text

West repurchased $231 million of stock in the third quarter, bringing year-to-date repurchases to $685 million. Cash-flow disclosures report $685.3 million of shares purchased under repurchase programs in the first nine months of 2026, versus $134.0 million in the prior-year period. Outstanding shares declined to 69.8 million at September 30, 2026, from 72.0 million at year-end 2025.

Key facts

Impact estimates

metricdirectionstageexpectedbasis
cashnegativerealized—West purchased $685.3 million of shares under share repurchase programs in the nine months ended September 30, 2026.